acid reflux on tirzepatide & Tirzepatide: What You Need to Know Understanding Tirzepatide Side Effects, Risks

Clinical Decision Summary Patients and clinicians weighing Mounjaro versus retatrutide face a choice between an approved, commercially accessible drug with 72-week phase 3 data and an investigational agent with 48-week phase 2 data that shows numerically superior weight loss but substantially higher GI discontinuation rates

For some women, these changes are temporary and improve as the body adjusts

[DOI] [PubMed] [Google Scholar] 167.Varshney P, Yadav V, Saini N

The same patient who successfully used Wegovy pens for six months can make a dosing error on their first compounded vial because the cognitive model is different